Figure 4From: Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastomaPlating efficiency (PE) for four GBM cell lines incubated for 5 h with or without 5 μM ABT-888. No significant difference in survival relative to untreated cells was observed (p > 0.8).Back to article page